menu
    • menu

    Company profile for Amgen Inc

    NEW Drugs in Dev: 181
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manu...
    Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Amgen IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Amgen Center Drive, Thousand Oaks, CA91320-1799
    Telephone
    Telephone
    +1 805-447-1000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.amgen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide
    EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide

    19 Feb 2026

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2026/2/euro-roundup-ema-seeks-feedback-on-plans-to-draft

    RAPS
    19 Feb 2026
    Share Share
    Matterworks Announces Update to Leadership Team
    Matterworks Announces Update to Leadership Team

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/matterworks-inc-announces-update-to-leadership-team-302689686.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    EU Approves Amgen's Uplizna for Generalized Myasthenia Gravis
    EU Approves Amgen's Uplizna for Generalized Myasthenia Gravis

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-approves-amgens-uplizna-for-generalized-myasthenia-gravis-302686432.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    Amgen to Present at Citi's 2026 Oncology Leadership Summit
    Amgen to Present at Citi's 2026 Oncology Leadership Summit

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2026-virtual-oncology-leadership-summit-302687989.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
    OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia

    06 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgen-kyowa-ox40-divorce-roche-rnai-deal-daiichi-adc-cull

    FIERCE PHARMA
    06 Feb 2026
    Share Share
    Amgen Thumbs-Down on FDA’s ask, Tavneos Sales Continue
    Amgen Thumbs-Down on FDA’s ask, Tavneos Sales Continue

    05 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgen-resists-fda-request-pull-rare-disease-drug-tavneos-market-0

    FIERCE PHARMA
    05 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Amgen Inc and get a quotation

    Amgen Inc is a supplier offers 11 products (APIs, Excipients or Intermediates).

    Find a price of INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by Amgen Inc

    Find a price of AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by Amgen Inc

    Find a price of AMG 282 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc

    Find a price of AMG 191 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc

    Find a price of AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by Amgen Inc

    Find a price of AMG 191 DRUG PRODUCT bulk with DMF offered by Amgen Inc

    Find a price of BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by Amgen Inc

    Find a price of HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by Amgen Inc

    Find a price of HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by Amgen Inc

    Find a price of Carfilzomib bulk offered by Amgen Inc

    Find a price of Recombinant Human Growth Hormone bulk offered by Amgen Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search